BCL2 immunostaining has been reported to increase with tumor grades in MN [21], but the dysregulation of the control of apoptosis could impact in both directions [42], suggesting a potential role of BCL2 losses in cell-death control that would agree with our findings. This evidence concerns the gene BCL2 and neoplasm.